Latin Times on MSN
PAHO and Gilead partner to bring biannual HIV prevention shots to 14 Latin American countriesPAHO and Gilead partner to bring twice-yearly lenacapavir HIV PrEP shots to 14 Latin American countries facing rising regional infection rates.
WELLINGTON, Sept 17 (Reuters) - Fiji has declared HIV a national crisis after new diagnoses climbed 27% last year, intensifying concern that an epidemic once concentrated among people who inject drugs ...
Surging drug use has contributed to an epidemic in the Pacific island nation, where one in 60 adults is estimated to be ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has expanded the scope of its six royalty-free voluntary licensing agreements for lenacapavir to include investigational once-yearly ...
Global health cuts caused real damage, but innovation and determination by countries, communities and partners helped prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results